π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study will test the hypotheses that a single dose of oxyntomodulin (OX...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01055340
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
This is a research study designed to evaluate the rate and extent of absorp...
Status
Completed
Location
LLC "Scientific and Research centre Eco-safety"
Start Date
2018-12-03
Trial ID
NCT03697889
Treatments Being Tested
Double Sequential External Defibrillation (DSED) represents an alternative ...
Status
Recruiting
Location
St Olavs Hospital
Start Date
2025-04-28
Trial ID
NCT06672159
Treatments Being Tested
compare the efficacy and safety of intravenous iron sucrose versus chelated...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05151679
Treatments Being Tested
a study to investigate the pharmacokinetic characteristics and safety/toler...
Status
Unknown
Location
Gachon University Gil Medical Center
Start Date
2019-04-01
Trial ID
NCT03920579
Treatments Being Tested
Prostate Cancer (PCa) screening is still a controversial topic in the urolo...
Status
Unknown
Location
Sapienza University of Rome
Start Date
2020-09-21
Trial ID
NCT04803188
Treatments Being Tested
GSK2798745 is a potent and selective transient receptor potential vanilloid...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-04-05
Trial ID
NCT03372603
Treatments Being Tested
This crossover experimental study aims to compare acute hamstring muscle ox...
Status
Recruiting
Location
Adana Olympic Preparation Center
Start Date
2026-07-01
Trial ID
NCT07715786
Treatments Being Tested
This will be a FTIH study which aims to evaluate safety, tolerability, phar...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-09-20
Trial ID
NCT05044325
Treatments Being Tested